Azomid 250 mg Tablets
PDF Leaflet Revision Date: 24 January 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Acute primary and secondary glaucoma.
Dosage (summary)
500 mg initially, then 250 mg every 6 to 8 hours.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Avoid in first trimester; low levels detected in breast milk.
Key Drug Interactions
- Potentiates effects of folic acid antagonists
- Increases lithium excretion
- May enhance effects of amphetamines
Contraindications
- Hypersensitivity to acetazolamide
- Sodium or potassium depletion
- Marked hepatic or renal failure
Common side effects
- Thirst
- Drowsiness
- Electrolyte imbalance
- Transient myopia
Counselling Points
- Report unusual skin rash
- Monitor for signs of suicidal ideation
- Periodic blood tests recommended
Serious warnings
- Risk of suicidal ideation
- Severe reactions to sulphonamides
- Caution in hepatic cirrhosis
Important Disclaimer
The Azomid 250 mg Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
